Literature DB >> 9182653

Physical activity and lipoprotein metabolism: epidemiological evidence and clinical trials.

A Berg1, M Halle, I Franz, J Keul.   

Abstract

Prospective epidemiological studies have proven a close link between the lipoprotein profile and cardiovascular morbidity and mortality. As physical activity is accepted as a significant factor improving physical fitness and lipoprotein metabolism, there is evidence that physically active men have a lower cardiovascular risk due to their higher metabolic fitness. Physical activity and physical fitness are generally linked to higher HDL cholesterol and lower LDL cholesterol as well as lower triglyceride and insulin levels. However, in cross-sectional studies the differences in lipoprotein cholesterol evaluated by routine measures in healthy physically active individuals and sedentary controls are only minor compared to therapeutical aims. The impact of exercise and training is often more significant when the effect of exercise on lipoprotein subfractions and apolipoprotein levels are taken into account. Dramatic differences can be documented in concentrations of cardioprotective HDL subset2 and atherogenic small, dense LDL subset6 levels in relation to the individual status of aerobic fitness and body composition in adults. These observations indicate that the preventive and therapeutical use of physical activity is of particular significance in a population of cardiovascular risk or patients with reduced daily activity. Our own experience in clinical trials shows that even in short-term programs (4 weeks to 6 months) changes in activity and eating behavior may lead to important improvements of the metabolic risk and lipid profile. Understanding the complex interaction between exercise and metabolic control of the lipid profile as well as the correlation with other risk parameters will improve the knowledge of prescribing exercise programs in patients at risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182653

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  9 in total

Review 1.  Health benefits of physical activity: the evidence.

Authors:  Darren E R Warburton; Crystal Whitney Nicol; Shannon S D Bredin
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

Review 2.  Exercise is Medicine - The Importance of Physical Activity, Exercise Training, Cardiorespiratory Fitness and Obesity in the Prevention and Treatment of Type 2 Diabetes.

Authors:  Carl J Lavie; Neil Johannsen; Damon Swift; Martin Sénéchal; Conrad Earnest; Timothy Church; Adrian Hutber; Robert Sallis; Steven N Blair
Journal:  Eur Endocrinol       Date:  2014-02-28

Review 3.  New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.

Authors:  Domenico Di Raimondo; Giuseppe Miceli; Gaia Musiari; Antonino Tuttolomondo; Antonio Pinto
Journal:  Ann Transl Med       Date:  2017-08

4.  The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Naoki Sakane; Nobuyuki Taniguchi
Journal:  J Clin Med Res       Date:  2012-05-15

5.  Effects of Combined Phase III and Phase II Cardiac Exercise Therapy for Middle-aged Male Patients with Acute Myocardial Infarction.

Authors:  Chih-Wei Lee; Ji-Hung Wang; Jen-Che Hsieh; Tsung-Cheng Hsieh; Chien-Hui Huang
Journal:  J Phys Ther Sci       Date:  2013-12-11

6.  Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men.

Authors:  Kota Fukai; Sei Harada; Miho Iida; Ayako Kurihara; Ayano Takeuchi; Kazuyo Kuwabara; Daisuke Sugiyama; Tomonori Okamura; Miki Akiyama; Yuji Nishiwaki; Yuko Oguma; Asako Suzuki; Chizuru Suzuki; Akiyoshi Hirayama; Masahiro Sugimoto; Tomoyoshi Soga; Masaru Tomita; Toru Takebayashi
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

7.  Fontan-Associated Dyslipidemia.

Authors:  Adam M Lubert; Tarek Alsaied; Joseph J Palermo; Nadeem Anwar; Elaine M Urbina; Nicole M Brown; Craig Alexander; Hassan Almeneisi; Fred Wu; Andrew R Leventhal; Nael Aldweib; Michael Mendelson; Alexander R Opotowsky
Journal:  J Am Heart Assoc       Date:  2021-03-31       Impact factor: 5.501

Review 8.  Cardiovascular disease and osteoporosis: balancing risk management.

Authors:  Darren E R Warburton; Crystal Whitney Nicol; Stephanie N Gatto; Shannon S D Bredin
Journal:  Vasc Health Risk Manag       Date:  2007

9.  Mid-arm muscle circumference as a substantial factor against mortality among people with elevated gamma gaps.

Authors:  Yuan-Ping Chao; Yi-Fen Lai; Tung-Wei Kao; Tao-Chun Peng; Yuan-Yung Lin; Mu-Tsun Shih; Wei-Liang Chen; Li-Wei Wu
Journal:  Oncotarget       Date:  2017-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.